Table 2.
Antifungal Therapy Prescribed and Identified Pathogen
| Pathogen (Episodes, Unique Patient) | MIC (mg/L) and Susceptibility* |
|---|---|
| Aspergillus fumigatus (episodes = 5, n = 4) | Amphotericin B: 1 |
| Isavuconazole: 0.5 | |
| Itraconazole: 0.125 | |
| Micafungin: ≤0.015 | |
| Voriconazole: 0.25 | |
|
| |
| Amphotericin B: 1 | |
| Micafungin: >32 | |
| Posaconazole: 0.5 | |
| Voriconazole: 1 | |
|
| |
| Amphotericin B: 1 | |
| Micafungin: ≤0.015 | |
| Voriconazole: 0.25 | |
|
| |
| Amphotericin B: 0.5 | |
| Micafungin: ≤0.015 | |
| Posaconazole: 0.06 | |
| Voriconazole: 1 | |
| Aspergillus flavus (episodes = 3, n = 2) | Amphotericin B: 1 |
| Voriconazole: 1 | |
|
| |
| Posaconazole: 0.25 | |
| Voriconazole: 1 | |
|
| |
| Amphotericin B: 0.25 | |
| Caspofungin: 0.5 | |
| Fluconazole: 2 | |
| Flucytosine: 0.5 | |
| Itraconazole: >32 | |
| Micafungin: ≤0.015 | |
| Posaconazole: >32 | |
| Voriconazole: 32 | |
| Candida tropicalis (episodes = 3, n = 2) | Amphotericin B: 1 |
| Anidulafungin: ≤0.015 (susceptible) | |
| Caspofungin: 0.015 (susceptible) | |
| Fluconazole: 2 (susceptible) | |
| Flucytosine: ≤0.060 (susceptible) | |
| Itraconazole: 0.25 (susceptible dose-dependent) | |
| Micafungin: 0.015 (susceptible) | |
| Posaconazole: 0.25 | |
| Voriconazole: 0.25 |